Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05767385 · ClinicalTrials.gov registry record · Phase 2
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
A Phase 2 study of Hypoxia and Neurodevelopmental Disorders, sponsored by University of Utah.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
- 5
- Study locations
NCT05767385: Recruiting Phase 2 study of Hypoxia and Neurodevelopmental Disorders, sponsored by University of Utah.
NCT05767385 is a Phase 2 study of Hypoxia and Neurodevelopmental Disorders that is actively recruiting participants, run by University of Utah. The registered enrollment target is 150 participants, below the 3,113-participant average among 39 other Hypoxia trials with a reported enrollment target (95% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05767385, a Phase 2 study of Hypoxia and Neurodevelopmental Disorders, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
- 5
- Study locations
Study Summary
Determine 1) the impact of abnormal fetal cerebrovascular physiology with neurodevelopmental delay (ND) outcomes and 2) how this relationship is modified by patient and environmental factors such as chronic congenital heart disease (CCHD) lesion, maternal-fetal environment, and social determinants of heath (SDOH) in a diverse population using a multicenter design. Pregnant women will be approached during one of their fetal cardiology clinic visits.
Primary Outcome
The NeoNatal Neurobehavioral Scale (NNNS-II) examines the neurobehavioral organization, neurological reflexes, motor development - active and passive tone, and signs of stress and withdrawal of the at-risk and drug-exposed infant
Conditions Studied
Interventions
- PROCEDURE Single Arm
- PROCEDURE Neonatal Neurobehavioral Scale
Study Locations (5)
Utah
- Primary Children's Hospital - Salt Lake City
- University of Utah - Salt Lake City
California
- University of California San Francisco - San Francisco
District of Columbia
- Children's National Medical Center - Washington D.C.
Maine
- Maine Medical Center - Scarborough
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-12-17 |
| Est. Completion | 2025-12 |
| Phase | Phase 2 |
What NCT05767385 shows while recruiting
NCT05767385 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 3,113-participant average among 39 other Hypoxia trials with a reported enrollment target (95% lower).
The record links to 4 conditions, with Hypoxia appearing as the primary indexed condition, and to 2 interventions - of which Single Arm is the first listed.
NCT05767385 lists 5 locations in 4 states (Utah, California, District of Columbia).
Frequently Asked Questions
What is clinical trial NCT05767385 about?
NCT05767385 is a clinical study titled "Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior". Determine 1) the impact of abnormal fetal cerebrovascular physiology with neurodevelopmental delay (ND) outcomes and 2) how this relationship is modified by patient and environmental factors such as chronic congenital heart disease (CCHD) lesion, maternal-fetal environment, and social determinants o...
What is the current status of trial NCT05767385?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2021-12-17. Estimated completion is 2025-12.
What conditions does trial NCT05767385 study?
This clinical trial studies the following conditions: Hypoxia, Neurodevelopmental Disorders, Congenital Heart Disease in Children, Complex Congenital Heart Disease.
What interventions are being tested in trial NCT05767385?
The interventions under investigation include: Single Arm (PROCEDURE), Neonatal Neurobehavioral Scale (PROCEDURE).
Who is sponsoring clinical trial NCT05767385?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05767385 being conducted?
This trial has 5 study locations across California, District of Columbia, Maine, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05767385's enrollment target sits among peer trials
150 8th of 39 higher than 32 of 39 other Hypoxia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypoxia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Breathing Training and Nitrate on Exercise at Simulated Altitude
RECRUITING · NA
-
Intravenous Iron Effects on Performance at High Altitude
RECRUITING · Phase 4
-
End-Tidal Oxygen for Intubation in the Emergency Department
RECRUITING · NA
-
Pulse Oximeter Accuracy in Healthy Humans During Hypoxia
RECRUITING
-
Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia
RECRUITING · Early Phase 1
-
Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI